Avivagen and Mimi’s Rock Announce Joint Venture for the Companion Animal Market


OTTAWA, Ontario & TORONTO–(BUSINESS WIRE)–Avivagen Inc. (TSXV:VIV) (“Avivagen” or the “Corporation”), owner of the intellectual property protected OxC-beta™ technology that supports the optimal health of companion animals, and Mimi’s Rock Corp. (TSXV:MIMI or “Mimi’s Rock”), an online dietary supplement and wellness company operating under the Dr. Tobias brand and with significant sales on the Amazon.com platform, are pleased to announce a Joint Venture agreement focused on the online sale of http://www.businesswire.com/news/home/20190613005091/en/Avivagen-Mimi%E2%80%99s-Rock-Announce-Joint-Venture-Companion/?feedref=JjAwJuNHiystnCoBq_hl-bQQCakZDujohEJegUyaJwquReQ0P23MrIoWkrUSV24ZevRMp3sIgu8q3wq1OF24lT93qbEzrwa15HGbLqMObxbNWfZlBntHS6jpH5ROLXsTFMkl05DM8ABqeyBleEmzJA==